Literature DB >> 9895401

Treating patients with severe sepsis.

A P Wheeler1, G R Bernard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9895401     DOI: 10.1056/NEJM199901213400307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  200 in total

1.  Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

Authors:  I Ginsburg
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

2.  Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures.

Authors:  V A Kempf; K Trebesius; I B Autenrieth
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Septic Shock and Toxic Shock: Do Adjunctive Therapies Improve Outcome?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 4.  Drug resistance in intensive care units.

Authors:  W C Albrich; M Angstwurm; L Bader; R Gärtner
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 5.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

6.  Learning patient-specific predictive models from clinical data.

Authors:  Shyam Visweswaran; Derek C Angus; Margaret Hsieh; Lisa Weissfeld; Donald Yealy; Gregory F Cooper
Journal:  J Biomed Inform       Date:  2010-05-05       Impact factor: 6.317

7.  Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

Authors:  J W Fijen; J G Zijlstra; P De Boer; R Spanjersberg; J W Tervaert; T S Van Der Werf; J J Ligtenberg; J E Tulleken
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

Review 8.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

9.  Adjunctive Therapies for Sepsis and Septic Shock.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

10.  Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis.

Authors:  Rebecca Elise Barnett; Daniel J Conklin; Lindsey Ryan; Robert C Keskey; Vikram Ramjee; Ernesto A Sepulveda; Sanjay Srivastava; Aruni Bhatnagar; William G Cheadle
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.